StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by Str8Shuteron Sep 22, 2020 1:14pm

143 Views

Post# 31597913

Free Likes for Level 2 Data Snapshots

For those who don't mind posting their view of L2 market data for SZLS, I almost always reward with a Like. I know that others very much appreciate it too. In my case, I simply don't feel that I do quite enough trading to make it worth while to pay for that premium service. Then again, I suppose I'm a bit of a cheapskate too. :-) GLTA

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments